Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Inflammatory Bowel Diseases

  Free Subscription


Articles published in J Clin Gastroenterol

Retrieve available abstracts of 78 articles:
HTML format



Single Articles


    July 2021
  1. HAIDER M, Lashner B
    Dual Targeted Therapy for the Management of Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2021 Jul 8. pii: 00004836-900000000-97396.
    PubMed     Abstract available


  2. CHANDAN S, Mohan BP, Kumar A, Khan SR, et al
    Safety and Efficacy of Biological Therapy in Chronic Antibiotic Refractory Pouchitis: A Systematic Review With Meta-analysis.
    J Clin Gastroenterol. 2021;55:481-491.
    PubMed     Abstract available


    June 2021
  3. BARNES EL, Hanson JS, Regueiro MD, Saha S, et al
    Older Adult Patients Use More Aminosalicylate Monotherapy Compared With Younger Patients With Inflammatory Bowel Disease: TARGET-IBD.
    J Clin Gastroenterol. 2021 Jun 11. pii: 00004836-900000000-97401.
    PubMed     Abstract available


    May 2021
  4. ZAMSTEIN O, Glusman Bendersky A, Sheiner E, Landau D, et al
    Association Between Mode of Delivery of the Breech Fetus and Hospitalizations Due to Inflammatory Bowel Disease During Childhood.
    J Clin Gastroenterol. 2021 May 28. pii: 00004836-900000000-97416.
    PubMed     Abstract available


  5. DOLINGER MT, Choi JJ, Phan BL, Rosenberg HK, et al
    Use of Small Bowel Ultrasound to Predict Response to Infliximab Induction in Pediatric Crohn's Disease.
    J Clin Gastroenterol. 2021;55:429-432.
    PubMed     Abstract available


    April 2021
  6. KOCHAR B, Jiang Y, Long MD
    Patients With Inflammatory Bowel Diseases Are at Higher Risk for Meningitis.
    J Clin Gastroenterol. 2021;55:350-354.
    PubMed     Abstract available


    February 2021
  7. SCHLABITZ F, Teich N, Riesner-Wehner A, Bohm S, et al
    Inflammatory Bowel Disease and COVID-19: How Have Patients Coped So Far?
    J Clin Gastroenterol. 2021 Feb 3. pii: 00004836-900000000-97473.
    PubMed     Abstract available


  8. HASHASH JG, Beatty PL, Critelli K, Hartman DJ, et al
    Altered Expression of the Epithelial Mucin MUC1 Accompanies Endoscopic Recurrence of Postoperative Crohn's Disease.
    J Clin Gastroenterol. 2021;55:127-133.
    PubMed     Abstract available


    January 2021
  9. BANERJEE R, Pal P, Adigopula B, Reddy DN, et al
    Impact of Demographic, Clinical and Psychosocial Variables on Drug Adherence and Outcomes in Indian Patients With Inflammatory Bowel Disease: Cost is not the Only Factor!
    J Clin Gastroenterol. 2021;Publish Ahead of Print.
    PubMed     Abstract available


  10. MORTENSEN JH, van Haaften WT, Karsdal MA, Bay-Jensen AC, et al
    The Citrullinated and MMP-degraded Vimentin Biomarker (VICM) Predicts Early Response to Anti-TNFalpha Treatment in Crohn's Disease.
    J Clin Gastroenterol. 2021;55:59-66.
    PubMed     Abstract available


    November 2020
  11. SCHWARTZ J, Stein DJ, Lipcsey M, Li B, et al
    High Rates of Mortality in Geriatric Patients Admitted for Inflammatory Bowel Disease Management.
    J Clin Gastroenterol. 2020 Nov 23. doi: 10.1097/MCG.0000000000001458.
    PubMed     Abstract available


    October 2020
  12. KREDENTSER MS, Graff LA, Bernstein CN
    Psychological Comorbidity and Intervention in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 27. doi: 10.1097/MCG.0000000000001463.
    PubMed     Abstract available


  13. EL AMROUSY D, El Ashry H, Hodeib H, Hassan S, et al
    Vitamin D in Children With Inflammatory Bowel Disease: A Randomized Controlled Clinical Trial.
    J Clin Gastroenterol. 2020 Oct 14. doi: 10.1097/MCG.0000000000001443.
    PubMed     Abstract available


  14. RITTER E, Hirsch A, Isakov NF, Ron Y, et al
    Higher Maintenance Adalimumab Trough Levels are Associated With Achievement of Advanced Remission Targets in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 14. doi: 10.1097/MCG.0000000000001435.
    PubMed     Abstract available


  15. CROOKS B, McLaughlin J, Limdi JK
    Disease-related Knowledge of People With Older-onset Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Oct 5. doi: 10.1097/MCG.0000000000001441.
    PubMed    


    September 2020
  16. BANERJEE R, Pal P, Penmetsa A, Kathi P, et al
    Novel Bioenhanced Curcumin With Mesalamine for Induction of Clinical and Endoscopic Remission in Mild-to-Moderate Ulcerative Colitis: A Randomized Double-Blind Placebo-controlled Pilot Study.
    J Clin Gastroenterol. 2020 Sep 4. doi: 10.1097/MCG.0000000000001416.
    PubMed     Abstract available


    August 2020
  17. SHIRZAD-ASKI H, Besharat S, Kienesberger S, Sohrabi A, et al
    Association Between Helicobacter pylori Colonization and Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2020 Aug 21. doi: 10.1097/MCG.0000000000001415.
    PubMed     Abstract available


  18. SHRESTHA MP, Taleban S
    Colectomy Rates Are Increasing Among Inpatients With Concomitant Ulcerative Colitis and Clostridioides difficile.
    J Clin Gastroenterol. 2020 Aug 14. doi: 10.1097/MCG.0000000000001412.
    PubMed     Abstract available


    July 2020
  19. MODESTO I
    Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative Colitis.
    J Clin Gastroenterol. 2020 Jul 29. doi: 10.1097/MCG.0000000000001404.
    PubMed    


  20. LEE SD, Shivashankar R, Quirk D, Zhang H, et al
    Therapeutic Drug Monitoring for Current and Investigational Inflammatory Bowel Disease Treatments.
    J Clin Gastroenterol. 2020 Jul 29. doi: 10.1097/MCG.0000000000001396.
    PubMed     Abstract available


  21. ELIAS ED, Bernstein CN, Singh H, Oketola A, et al
    Dose Augmentation of Tumor Necrosis Factor Inhibitors is Frequently Performed in Persons With Inflammatory Bowel Disease in the Absence of Objective Evidence of Active Inflammation.
    J Clin Gastroenterol. 2020 Jul 17. doi: 10.1097/MCG.0000000000001391.
    PubMed     Abstract available


  22. FRESAN ORELLANA A, Parra Holguin NN, Yamamoto-Furusho JK
    Mental Health Factors Associated With Fatigue in Mexican Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2020 Jul 14. doi: 10.1097/MCG.0000000000001397.
    PubMed     Abstract available


  23. DOEVE BH, van de Meeberg MM, van Schaik FDM, Fidder HH, et al
    A Systematic Review With Meta-Analysis of the Efficacy of Cannabis and Cannabinoids for Inflammatory Bowel Disease: What Can We Learn From Randomized and Nonrandomized Studies?
    J Clin Gastroenterol. 2020 Jul 14. doi: 10.1097/MCG.0000000000001393.
    PubMed     Abstract available


  24. FAN L, Wong M, Fan XS, Hong Y, et al
    Quantitative Analysis of Intramucosal Mast Cells in Irritable Bowel Syndrome: A Comparison With Inflammatory Bowel Disease in Remission.
    J Clin Gastroenterol. 2020 Jul 8. doi: 10.1097/MCG.0000000000001394.
    PubMed     Abstract available


    June 2020
  25. ALMON E, Shaaltiel Y, Sbeit W, Fich A, et al
    Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis: Results From a Phase 2a Clinical Trial.
    J Clin Gastroenterol. 2020 Jun 3. doi: 10.1097/MCG.0000000000001314.
    PubMed     Abstract available


    April 2020
  26. SCHOFFEL N, Bruggmann D, Klingelhofer D, Bendels MHK, et al
    Ulcerative Colitis: A Critical Approach to the Global Research Output Employing Density-equalizing Mapping and Scientometric Methods.
    J Clin Gastroenterol. 2020 Apr 21. doi: 10.1097/MCG.0000000000001351.
    PubMed     Abstract available


  27. CAMPBELL JP, Zierold C, Rode AM, Blocki FA, et al
    Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.
    J Clin Gastroenterol. 2020 Apr 21. doi: 10.1097/MCG.0000000000001359.
    PubMed     Abstract available


    January 2020
  28. HELWIG U, Kostev K, Schmidt C
    Comparative Analysis of 3-Year Persistence With Vedolizumab Compared With Antibodies Against Tumor Necrosis Factor-Alpha in Patients With Inflammatory Bowel Disease in Germany: Retrospective Analysis of a Large Prescription Database.
    J Clin Gastroenterol. 2020 Jan 31. doi: 10.1097/MCG.0000000000001323.
    PubMed     Abstract available


    November 2019
  29. DETREZ I, Thomas D, Van Steen K, Ballet V, et al
    Successful Infliximab Treatment is Associated With Reversal of Clotting Abnormalities in Inflammatory Bowel Disease Patients.
    J Clin Gastroenterol. 2019 Nov 26. doi: 10.1097/MCG.0000000000001290.
    PubMed     Abstract available


  30. KIM JY, Yoon H, Hwang JS, Yang SK, et al
    Comparison of Disease-related Knowledge of Patients With Inflammatory Bowel Disease Between the West and the East Using an Updated Questionnaire (IBD-KNOW).
    J Clin Gastroenterol. 2019 Nov 19. doi: 10.1097/MCG.0000000000001283.
    PubMed     Abstract available


    September 2019
  31. DAI C, Jiang M, Sun MJ
    Oral Nano Vitamin D Supplementation and Disease Activity in Ulcerative Colitis.
    J Clin Gastroenterol. 2019 Sep 12. doi: 10.1097/MCG.0000000000001263.
    PubMed    


    August 2019
  32. ANTONELLI E, Torti G, Bassotti G
    Inhibitors of the Janus Kinases: A New Oral Treatment Option for Ulcerative Colitis.
    J Clin Gastroenterol. 2019 Aug 1. doi: 10.1097/MCG.0000000000001250.
    PubMed     Abstract available


    July 2019
  33. AHAMED Z R, Dutta U, Sharma V, Prasad KK, et al
    Oral Nano Vitamin D Supplementation Reduces Disease Activity in Ulcerative Colitis: A Double-Blind Randomized Parallel Group Placebo-controlled Trial.
    J Clin Gastroenterol. 2019 Jul 26. doi: 10.1097/MCG.0000000000001233.
    PubMed     Abstract available


  34. TANDON P, Leung K, Yusuf A, Huang VW, et al
    Noninvasive Methods For Assessing Inflammatory Bowel Disease Activity in Pregnancy: A Systematic Review.
    J Clin Gastroenterol. 2019 Jul 12. doi: 10.1097/MCG.0000000000001244.
    PubMed     Abstract available


    April 2019
  35. GALOOSIAN A, Rezapour M, Liu B, Bhuket T, et al
    Race/Ethnicity-specific Disparities in In-Hospital Mortality and Hospital Charges Among Inflammatory Bowel Disease-related Hospitalizations in the United States.
    J Clin Gastroenterol. 2019 Apr 17. doi: 10.1097/MCG.0000000000001204.
    PubMed     Abstract available


  36. DAI C, Jiang M, Sun MJ, Cao Q, et al
    Fecal Lactoferrin for Assessment of Inflammatory Bowel Disease Activity: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2019 Apr 15. doi: 10.1097/MCG.0000000000001212.
    PubMed     Abstract available


    March 2019
  37. CAPURSO L
    Thirty Years of Lactobacillus rhamnosus GG: A Review.
    J Clin Gastroenterol. 2019;53 Suppl 1:S1-S41.
    PubMed     Abstract available


    January 2019
  38. HASHASH JG, Vachon A, Ramos Rivers C, Regueiro MD, et al
    Predictors of Suicidal Ideation Among IBD Outpatients.
    J Clin Gastroenterol. 2019;53:e41-e45.
    PubMed     Abstract available


    August 2018
  39. LV XH, Wang BL, Cao GW
    Narrow Band Imaging for Surveillance in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2018 Aug 9. doi: 10.1097/MCG.0000000000001101.
    PubMed     Abstract available


    July 2018
  40. SHAMBERG L, Vaziri H
    Hepatotoxicity of Inflammatory Bowel Disease Medications.
    J Clin Gastroenterol. 2018 Jul 20. doi: 10.1097/MCG.0000000000001084.
    PubMed     Abstract available


    May 2018
  41. SHAH A, Walker M, Burger D, Martin N, et al
    Link Between Celiac Disease and Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2018 May 14. doi: 10.1097/MCG.0000000000001033.
    PubMed     Abstract available


    February 2018
  42. CASSINOTTI A, Buffoli F, Fociani P, Staiano T, et al
    Virtual Chromoendoscopy With FICE for the Classification of Polypoid and Nonpolypoid Raised Lesions in Ulcerative Colitis.
    J Clin Gastroenterol. 2018 Feb 1. doi: 10.1097/MCG.0000000000000974.
    PubMed     Abstract available


    January 2018
  43. DAI C, Jiang M, Sun MJ
    The Impact of Clostridium difficile Infection on Mortality in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2018 Jan 23. doi: 10.1097/MCG.0000000000000996.
    PubMed    


  44. KORELITZ BI, Sonpal N, Schneider J, Swaminath A, et al
    Obesity/Bariatric Surgery and Crohn's Disease.
    J Clin Gastroenterol. 2018;52:50-54.
    PubMed     Abstract available


  45. NIV Y, Gal E, Gabovitz V, Hershkovitz M, et al
    Capsule Endoscopy Crohn's Disease Activity Index (CECDAIic or Niv Score) for the Small Bowel and Colon.
    J Clin Gastroenterol. 2018;52:45-49.
    PubMed     Abstract available


    December 2017
  46. KREIJNE JE, van der Giessen J, Verhaar AP, Peppelenbosch MM, et al
    Fecal Matrix Metalloproteinase-9 Measurement for Optimizing Detection of Disease Activity in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2017 Dec 18. doi: 10.1097/MCG.0000000000000952.
    PubMed    


  47. TARIQ R, Law CCY, Khanna S, Murthy S, et al
    The Impact of Clostridium difficile Infection on Mortality in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2017 Dec 4. doi: 10.1097/MCG.0000000000000968.
    PubMed     Abstract available


    November 2017
  48. ZHONG W, Lu X, Shi H, Zhao G, et al
    Distinct Microbial Populations Exist in the Mucosa-associated Microbiota of Diarrhea Predominant Irritable Bowel Syndrome and Ulcerative Colitis.
    J Clin Gastroenterol. 2017 Nov 28. doi: 10.1097/MCG.0000000000000961.
    PubMed     Abstract available


    September 2017
  49. BEN-HORIN S, Mao R, Qiu Y, Chen M, et al
    Discontinuation of Biological Treatments in Inflammatory Bowel Disease: A Concise Pragmatic Review.
    J Clin Gastroenterol. 2017 Sep 29. doi: 10.1097/MCG.0000000000000938.
    PubMed     Abstract available


    August 2017
  50. FABISIAK N, Fabisiak A, Watala C, Fichna J, et al
    Fat-soluble Vitamin Deficiencies and Inflammatory Bowel Disease: Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2017 Aug 30. doi: 10.1097/MCG.0000000000000911.
    PubMed     Abstract available


  51. KORELITZ BI, Kesar V, Taunk R, Schneider J, et al
    Sequential Crohn's Ileitis, Ileosigmoidal Fistula, Segmental Sigmoid Polyposis, and Sigmoid Stricture: The Natural History.
    J Clin Gastroenterol. 2017;51:607-610.
    PubMed     Abstract available


    July 2017
  52. GIBSON DJ, Hartery K, Doherty J, Nolan J, et al
    CRP/Albumin Ratio: An Early Predictor of Steroid Responsiveness in Acute Severe Ulcerative Colitis.
    J Clin Gastroenterol. 2017 Jul 21. doi: 10.1097/MCG.0000000000000884.
    PubMed     Abstract available


  53. GROSSBERG LB, Falchuk K, Feuerstein JD
    Reply to Potential Pitfalls When Assessing the Impact of Cytomegalovirus in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2017 Jul 10. doi: 10.1097/MCG.0000000000000848.
    PubMed    


    June 2017
  54. SOKOLLIK C, Fournier N, Rizzuti D, Braegger CP, et al
    The Use of 5-Aminosalicylic Acid in Children and Adolescents With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2017 Jun 21. doi: 10.1097/MCG.0000000000000864.
    PubMed     Abstract available


    May 2017
  55. FERREIRO-IGLESIAS R, Barreiro-de Acosta M, Dominguez-Munoz JE
    Reply to: Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients.
    J Clin Gastroenterol. 2017 May 17. doi: 10.1097/MCG.0000000000000839.
    PubMed    


    April 2017
  56. CLICK B, Anderson AM, Ramos Rivers C, Koutroubakis IE, et al
    Telephone Encounters Predict Future High Financial Expenditures in Inflammatory Bowel Disease Patients: A 3-Year Prospective Observational Study.
    J Clin Gastroenterol. 2017 Apr 27. doi: 10.1097/MCG.0000000000000801.
    PubMed     Abstract available


    March 2017
  57. MCCURDY JD, Bruining DH, Loftus EV Jr
    Potential Pitfalls When Assessing the Impact of Cytomegalovirus in Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2017 Mar 8. doi: 10.1097/MCG.0000000000000812.
    PubMed    


    February 2017
  58. DAI C, Cao Q, Jiang M
    Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients.
    J Clin Gastroenterol. 2017 Feb 2. doi: 10.1097/MCG.0000000000000807.
    PubMed    


    January 2017
  59. RINAWI F, Assa A, Hartman C, Mozer Glassberg Y, et al
    Long-term Extent Change of Pediatric-Onset Ulcerative Colitis.
    J Clin Gastroenterol. 2017 Jan 6. doi: 10.1097/MCG.0000000000000741.
    PubMed     Abstract available


  60. BJORNSSON ES, Gu J, Kleiner DE, Chalasani N, et al
    Azathioprine and 6-Mercaptopurine-induced Liver Injury: Clinical Features and Outcomes.
    J Clin Gastroenterol. 2017;51:63-69.
    PubMed     Abstract available


  61. BRENNAN GT, Melton SD, Spechler SJ, Feagins LA, et al
    Clinical Implications of Histologic Abnormalities in Ileocolonic Biopsies of Patients With Crohn's Disease in Remission.
    J Clin Gastroenterol. 2017;51:43-48.
    PubMed     Abstract available


    December 2016
  62. SUSKIND DL, Cohen SA, Brittnacher MJ, Wahbeh G, et al
    Clinical and Fecal Microbial Changes With Diet Therapy in Active Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016 Dec 27. doi: 10.1097/MCG.0000000000000772.
    PubMed     Abstract available


  63. SHAH SC, Naymagon S, Cohen BL, Sands BE, et al
    There is Significant Practice Pattern Variability in the Management of the Hospitalized Ulcerative Colitis Patient at a Tertiary Care and IBD Referral Center.
    J Clin Gastroenterol. 2016 Dec 22. doi: 10.1097/MCG.0000000000000779.
    PubMed     Abstract available


  64. DU L, Foshaug R, Huang VW, Kroeker KI, et al
    Within-Stool and Within-Day Sample Variability of Fecal Calprotectin in Patients With Inflammatory Bowel Disease: A Prospective Observational Study.
    J Clin Gastroenterol. 2016 Dec 22. doi: 10.1097/MCG.0000000000000776.
    PubMed     Abstract available


  65. FERREIRO-IGLESIAS R, Barreiro-de Acosta M, Lorenzo-Gonzalez A, Dominguez-Munoz JE, et al
    Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy: A Prospective Longitudinal Cohort Study.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


    November 2016
  66. SHUKLA T, Singh S, Tandon P, McCurdy JD, et al
    Corticosteroids and Thiopurines, But Not Tumor Necrosis Factor Antagonists, are Associated With Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


  67. WANG Y, Aggarwal P, Liu X, Lu H, et al
    Antiviral Treatment for Colonic Cytomegalovirus Infection in Ulcerative Colitis Patients Significantly Improved Their Surgery Free Survival.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


  68. STRISCIUGLIO C, Bellini G, Miele E, Martinelli M, et al
    Cannabinoid Receptor 2 Functional Variant Contributes to the Risk for Pediatric Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


  69. GROSSBERG LB, Ezaz G, Grunwald D, Cohen J, et al
    A National Survey of the Prevalence and Impact of Cytomegalovirus Infection Among Hospitalized Patients With Ulcerative Colitis.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


  70. BERNSTEIN CN, Eliakim A, Fedail S, Fried M, et al
    World Gastroenterology Organisation Global Guidelines Inflammatory Bowel Disease: Update August 2015.
    J Clin Gastroenterol. 2016;50:803-818.
    PubMed    


    October 2016
  71. TSEN A, Alishahi Y, Rosenkranz L
    Autoimmune Pancreatitis and Inflammatory Bowel Disease: An Updated Review.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


  72. HASHASH JG, Ramos-Rivers C, Youk A, Chiu WK, et al
    Quality of Sleep and Coexistent Psychopathology Have Significant Impact on Fatigue Burden in Patients With Inflammatory Bowel Disease.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


  73. CASSIERI C, Pica R, Avallone EV, Zippi M, et al
    Prevalence of Colonic Diverticulosis in Patients Affected by Ulcerative Colitis: A Prospective Study.
    J Clin Gastroenterol. 2016;50 Suppl 1:S33-5.
    PubMed     Abstract available


    September 2016
  74. CORICA D, Romano C
    Biological Therapy in Pediatric Inflammatory Bowel Disease: A Systematic Review.
    J Clin Gastroenterol. 2016.
    PubMed     Abstract available


    May 2016
  75. CARVALHANA S, Goncalves A, Velosa J
    Cutaneous Pseudolymphoma in a Patient With Crohn's Disease Under Infliximab: First Report.
    J Clin Gastroenterol. 2016;50:436-7.
    PubMed    


    April 2016
  76. SAYAR E, Yucel A, Eisele B, Sayar EH, et al
    The Ineffectiveness of Tacrolimus in an Infant With a Mutation in the IL-10 Receptor.
    J Clin Gastroenterol. 2016;50:352-3.
    PubMed    


  77. FERGES W, Rampertab SD, Shafqet M, Salimi Q, et al
    Experience With Anti-TNF-alpha Biologic Agents in Succession in Patients With Crohn's Disease: A Retrospective Analysis of a Single Center.
    J Clin Gastroenterol. 2016;50:326-30.
    PubMed     Abstract available


    January 2016
  78. ABREU C, Carvalho T, Sarmento A, Magro F, et al
    Stool Isolation of Nocardia nova in Two Immunomodulated Patients With Inflammatory Bowel Diseases.
    J Clin Gastroenterol. 2016;50:92.
    PubMed    


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: